top of page
  • Writer's picturePreferUS Healthcare

PreferUS EVP Named New CEO of Shanghai Guolong Hospital

Updated: Nov 30, 2018

 (Shanghai, China) June 4, 2018

On May 10, 2018, PreferUS Healthcare – China partner, Guolong Medical Group, held a ceremony to appoint PreferUS Executive Vice President of China Operations, David Farrick, as their new CEO of the Shanghai Guolong Hospital. Farrick, who will be based in Shanghai, brings a wealth of experience in hospital management and will strongly contribute in elevating the Shanghai Guolong Hospital to an international standards hospital group.

“PreferUS is a U.S.-based leader in the Chinese market for hospital management, consulting and investment services. As a member of the PreferUS team, I’m excited to be the CEO of the Shanghai Guolong Hospital.” said Farrick. He continued “the hospital serves the people of Zhou Pu, a sub-community of Shanghai. Together with the hospital staff and the PreferUS team, I look forward to bringing a higher level of international medical quality and patient service standards to the community. The PreferUS team, together with our U.S.-based partners, has a depth of knowledge and talent from which we can draw upon.”

Since 2008, PreferUS has been immersed in China healthcare and is positioned uniquely for the growth that is taking place within the China healthcare market. Our U.S. Institutional Partners; Cedars-Sinai Medical Center, Kerlan-Jobe Orthopedic Clinic, Oklahoma Heart Hospital and Texas Back Institute are internationally recognized and highly respected amongst our China-based partners. Our relationship with Guolong Medical Group has set the standard for future partners as we have invested into the group and established an ongoing consulting engagement which has led to managing the Shanghai Guolong Hospital. The significance of our partnership with Guolong shows that PreferUS has successfully executed on all three fronts of our mission of hospital investment, consulting and management.

PreferUS EVP-China Operations, David M. Farrick


bottom of page